Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Taxis Pharmaceuticals

Taxis Pharmaceuticals
2009 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Angel LATEST DEAL TYPE
$1.14M LATEST DEAL AMOUNT
Description

Developer of antibiotics and antiviral drugs designed to address the global health crisis of antimicrobial resistance. The company's drugs are mostly antibiotics and therapeutic agents that employ novel mechanisms of action distinct from those currently in clinical use, enabling physicians to treat methicillin-resistant Staphylococcus aureus (MRSA) affected patients.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • 9 Deer Park Drive
  • Suite J-15
  • Monmouth Junction, NJ 08852
  • United States

+1 (732) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Taxis Pharmaceuticals’s full profile, request a free trial.

Taxis Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Angel (individual) 09-Jan-2019 $1.14M 000.00 Completed Generating Revenue
4. Angel (individual) 25-Sep-2017 Cancelled Generating Revenue
3. Angel (individual) 10-Mar-2017 00.00 000.00 Completed Generating Revenue
2. Angel (individual) 22-Jul-2015 $2M $8.5M 000.00 Completed Generating Revenue
1. Angel (individual) 13-Apr-2015 $6.5M $6.5M 0000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Taxis Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00
Series A 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

Taxis Pharmaceuticals Executive Team (4)

Name Title Board
Seat
Contact
Info
Gregory Mario President, Chief Executive Officer and Board Member
Daniel Pilch Ph.D Co-Founder
Henry Chambers MD Scientific Advisor
Edmond LaVoie Ph.D Co-Founder & Board Member

Taxis Pharmaceuticals Board Members (5)

Name Representing Role Since Contact
Info
Christopher Cimarusti Taxis Pharmaceuticals Board Member 000 0000
Edmond LaVoie Ph.D Self Co-Founder & Board Member 000 0000
Ernest Mario Ph.D Taxis Pharmaceuticals Board Member 000 0000
Gail McIntyre Ph.D Self Board Member 000 0000
S. David Kimball Ph.D Self Board Member 000 0000